Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study-Reference-Cited by-同舟云学术

Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study

Published:2019-07-31 Issue:5 Volume:21 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Naik Seema¹^ORCID,Riches Marcie²,Hari Parameswaran³,Kim Soyoung³⁴,Chen Min³,Bachier Carlos⁵,Shaughnessy Paul⁶,Hill Joshua⁷,Ljungman Per⁸,Battiwalla Minoo⁵,Chhabra Saurabh⁹,Daly Andrew¹⁰,Storek Jan¹¹,Ustun Celalettin¹²,Diaz Miguel Angel¹³,Cerny Jan¹⁴,Beitinjaneh Amer¹⁵,Yared Jean¹⁶,Brown Valerie¹⁷,Page Kristin¹⁸,Dahi Parastoo B.¹⁹,Ganguly Siddhartha²⁰,Seo Sachiko²¹,Chao Nelson²²,Freytes Cesar O.⁶,Saad Ayman²³,Savani Bipin N.²⁴,Woo Ahn Kwang³⁴,Boeckh Michael²⁵,Heslop Helen E.²⁶,Lazarus Hillard M.²⁷,Auletta Jeffery J.²⁸,Kamble Rammurti T.²⁶

Affiliation:

1. Penn State Cancer Institute Hershey Pennsylvania

2. Division of Hematology/Oncology The University of North Carolina Chapel Hill North California

3. Department of Medicine, Medical College of Wisconsin Center for International Blood and Marrow Transplant Research (CIBMTR) Milwaukee Wisconsin

4. Division of Biostatistics, Institute for Health and Equity Medical College of Wisconsin Milwaukee Wisconsin

5. Sarah Cannon Center for Blood Cancer Nashville Tennessee

6. Texas Transplant Institute Sarah Cannon Blood Cancer Network San Antonio Texas

7. Fred Hutchinson Cancer Research Center Seattle Washington

8. Department of Cellular Therapy and Allogeneic Stem Cell Transplantation Karolinska University Hospital Stockholm Sweden

9. Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR) Medical College of Wisconsin Milwaukee Wisconsin

10. Tom Baker Cancer Centre Calgary AB Canada

11. Department of Medicine University of Calgary Calgary AB Canada

12. Division of Hematology, Oncology and Transplantation, Department of Medicine University of Minnesota Medical Center Minneapolis Minnesota

13. Department of Hematology/Oncology Hospital Infantil Universitario Nino Jesus Madrid Spain

14. UMass Memorial Medical Center Worcester Massachusetts

15. University of Miami Miami Florida

16. Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center University of Maryland Baltimore Maryland

17. Division of Pediatric Oncology/Hematology, Department of Pediatrics Penn State Hershey Children's Hospital and College of Medicine Hershey Pennsylvania

18. Division of Pediatric Blood and Marrow Transplantation Duke University Medical Center Durham North Carolina

19. Department of Medicine, Adult Bone Marrow Transplant Service Memorial Sloan Kettering Cancer Center New York New York

20. Division of Hematological Malignancy and Cellular Therapeutics University of Kansas Health System Kansas City Kansas

21. Department of Hematology, Oncology Dokkyo Medical University Tochigi Japan

22. Division of Cell Therapy and Hematologica, Department of Medicine Duke University Medical Center Durham North Carolina

23. Division of Hematology/Oncology, Department of Medicine University of Alabama at Birmingham Birmingham Alabama

24. Division of Hematology/Oncology, Department of Medicine Vanderbilt University Medical Center Nashville Tennessee

25. Vaccine and Infectious Disease Division Fred Hutchinson Cancer Research Center Seattle, Washington

26. Division of Hematology and Oncology, Center for Cell and Gene Therapy Baylor College of Medicine Houston Texas

27. Seidman Cancer Center, University Hospitals Cleveland Medical Center Case Western Reserve University Cleveland Ohio

28. Blood and Marrow Transplant Program and Host Defense Program, Divisions of Hematology/Oncology/Bone Marrow Transplant and Infectious Diseases Nationwide Children's Hospital Columbus Ohio

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13145

Reference26 articles.

1. EBV-Associated Lymphoproliferative Disorders: Classification and Treatment

2. Post-Transplant Lymphoproliferative Disorders

3. How I treat EBV lymphoproliferation

4. Post-Transplant Lymphoproliferative Disorders

5. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiating Between Epstein-Barr Virus–positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation;American Journal of Surgical Pathology;2024-01-30

2. T-Cell Posttransplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Systemic Review;Cell Transplantation;2024-01

3. Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study;Frontiers in Oncology;2023-06-23

4. Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation;Blood;2023-03-09

5. 造血細胞移植後二次がんへの対策;Japanese Journal of Transplantation and Cellular Therapy;2023